Relmada Therapeutics (RLMD) Prepaid Assets (2012 - 2026)

Relmada Therapeutics (RLMD) has reported Prepaid Assets for 14 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets rose 918.56% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 918.56% YoY), while the FY2025 annual figure was $977721.0, up 10.29% from the prior year.
• Prepaid Assets rose to $1.4 million in Q1 2026 per RLMD's latest filing, from $977721.0 in the prior quarter.
• Across five years, Prepaid Assets topped out at $4.0 million in Q4 2022 and bottomed at $99500.0 in Q2 2025.
• Historically, Prepaid Assets has averaged $1.6 million across 5 years, with a median of $967700.0 in 2025.
• Annual changes were most pronounced in 2022 — Prepaid Assets jumped 4430.17% — and 2024, when it plunged 91.42%.
• Relmada Therapeutics' Prepaid Assets stood at $4.0 million in 2022, then tumbled by 82.78% to $695000.0 in 2023, then rose by 27.55% to $886461.0 in 2024, then advanced by 10.29% to $977721.0 in 2025, then surged by 41.16% to $1.4 million in 2026.
• Business Quant data shows RLMD's Prepaid Assets at $1.4 million in Q1 2026, $977721.0 in Q4 2025, and $967700.0 in Q3 2025.